Celiac Disease - NIH Consensus Development Program - National ...

More documents

Recommendations

Info

AGENDAMonday, June 28, 20048:30 a.m. Opening RemarksAllen M. Spiegel, M.D.DirectorNational Institute of Diabetes and Digestive and Kidney DiseasesNational Institutes of Health8:40 a.m. Charge to the PanelSusan Rossi, Ph.D., M.P.H.Deputy DirectorOffice of Medical Applications of Research, Office of the DirectorNational Institutes of Health8:50 a.m. Conference Overview and Panel ActivitiesCharles O. Elson, M.D.Panel and Conference ChairpersonProfessor of Medicine and MicrobiologyVice Chair for Research, Department of MedicineUniversity of Alabama at BirminghamI. How Is Celiac Disease Diagnosed?9:00 a.m. Overview and Pathogenesis of Celiac DiseaseMartin F. Kagnoff, M.D.Professor of Medicine and PediatricsCancer Biology ProgramUniversity of California at San Diego9:20 a.m. The Pathology of Celiac DiseasePaul J. Ciclitira, M.D., Ph.D., FRCPProfessorThe Rayne InstituteSt. Thomas’ HospitalUnited Kingdom9:40 a.m. What Are the Sensitivity and Specificity of Serological Tests for Celiac Disease?Do Sensitivity and Specificity Vary in Different Populations?Ivor D. Hill, M.D.Professor of PediatricsWake Forest University School of Medicine3
Monday, June 28, 2004 (continued)I. How Is Celiac Disease Diagnosed? (continued)10:00 a.m. DiscussionParticipants with questions or comments for the speakers should proceed to themicrophones and wait to be recognized by the panel chair. Please state yourname and affiliation. Questions and comments not heard before the close of thediscussion period may be submitted at the registration desk. Please be aware thatall statements made at the microphone or submitted later are in the publicdomain.10:30 a.m. Clinical Algorithm in Celiac DiseaseCiaran P. Kelly, M.D.Director, Celiac CenterHerrman L. Blumgart Firm ChiefDirector, Gastroenterology Fellowship TrainingAssociate Professor of MedicineBeth Israel Deaconess Medical CenterHarvard Medical School10:50 a.m. Genetic Testing: Who Should Do the Testing and What Is the Role of GeneticTesting in the Setting of Celiac Disease?George S. Eisenbarth, M.D.Executive DirectorBarbara Davis Center for Childhood DiabetesUniversity of Colorado Health Sciences Center11:10 a.m. Evidence-Based Practice Center Presentation: Serological Testing forCeliac DiseaseAlaa Rostom, M.D., M.Sc., FRCPCAssistant ProfessorDivision of GastroenterologyUniversity of OttawaThe Ottawa Hospital – Civic Campus11:30 a.m. Discussion12:00 p.m. Lunch4
Page 1 and 2: NIH Consensus Development Conferenc
Page 3 and 4: III. What Are the Manifestations an
Page 5: • What is the management of celia
Page 9 and 10: Monday, June 28, 2004 (continued)II
Page 11 and 12: Wednesday, June 30, 2004 (continued
Page 13 and 14: Lisa H. RichardsonConsumer Represen
Page 15 and 16: Ciaran P. Kelly, M.D.Director, Celi
Page 17 and 18: Van S. Hubbard, M.D., Ph.D.Director
Page 19 and 20: AbstractsThe following are abstract
Page 21 and 22: susceptibility (e.g., DR17 homozygo
Page 23 and 24: The Pathology of Celiac DiseaseDavi
Page 25 and 26: In this regard, the transport pathw
Page 27 and 28: for the IgG-based test, while speci
Page 29 and 30: 15. de Lecea A, Ribes-Koninckx C, P
Page 31 and 32: Clinical Algorithm in Celiac Diseas
Page 33 and 34: Considera diagnosisof celiac diseas
Page 35 and 36: There are populations at particular
Page 37 and 38: Serological Testing for Celiac Dise
Page 39 and 40: Estimates of the sensitivity of the
Page 41 and 42: the risk and severity of CD may als
Page 43 and 44: What Are the Prevalence and Inciden
Page 45 and 46: ascribed to excess menstrual loss.
Page 47 and 48: ReferencesFamily History of Celiac
Page 49 and 50: Carroccio A, Iannitto E, Cavataio F
Page 51 and 52: identified by surveys or through so
Page 53 and 54: Clinical Presentation of Celiac Dis
Page 55 and 56: een widely reported. The question r
Page 57 and 58:
The Many Faces of Celiac Disease: C
Page 59 and 60:
References1. Green PH, Jabri B. Coe
Page 61 and 62:
Association of Celiac Disease and G
Page 63 and 64:
Does the Gluten-Free Diet Protect F
Page 65 and 66:
Skin Manifestations of Celiac Disea
Page 67 and 68:
allow a better understanding of the
Page 69 and 70:
4. Henriksson KG, Hallert C, Walan
Page 71 and 72:
characterized, clinically-identifie
Page 73 and 74:
10. Hoffenberg EJ, Emery LM, Barrig
Page 75 and 76:
ataxia, epilepsy with posterior cer
Page 77 and 78:
Consequences of Testing for Celiac
Page 79 and 80:
Osteoporosis/FracturesThere were 11
Page 81 and 82:
Dietary Guidelines for Celiac Disea
Page 85 and 86:
21. Thompson T. Thiamin, riboflavin
Page 88 and 89:
In order to effectively counsel ind
Page 90 and 91:
9. Hallert C, Granno C, Hulten S, M
Page 92 and 93:
adhered to the GFD after more than
Page 94 and 95:
Patient education, close supervisio
Page 96:
26. Mustalahti K, Lohiniemi S, Laip
show all

Celiac Disease - NIH Consensus Development Program - National ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?